TOMMASINI, Silvana
 Distribuzione geografica
Continente #
EU - Europa 7.722
NA - Nord America 7.139
AS - Asia 4.008
SA - Sud America 1.256
Continente sconosciuto - Info sul continente non disponibili 134
AF - Africa 124
OC - Oceania 10
Totale 20.393
Nazione #
US - Stati Uniti d'America 7.027
RU - Federazione Russa 3.736
SG - Singapore 1.672
CN - Cina 1.149
BR - Brasile 1.098
IE - Irlanda 1.008
SE - Svezia 851
UA - Ucraina 498
HK - Hong Kong 446
DE - Germania 416
VN - Vietnam 269
IT - Italia 252
GB - Regno Unito 250
FI - Finlandia 233
FR - Francia 213
IN - India 135
PL - Polonia 74
AT - Austria 60
AR - Argentina 53
BD - Bangladesh 53
CA - Canada 50
TR - Turchia 40
MX - Messico 35
IQ - Iraq 34
ZA - Sudafrica 31
EC - Ecuador 27
MA - Marocco 26
ID - Indonesia 25
CI - Costa d'Avorio 24
NL - Olanda 24
ES - Italia 23
JP - Giappone 23
PK - Pakistan 20
UZ - Uzbekistan 20
VE - Venezuela 20
BE - Belgio 18
CZ - Repubblica Ceca 17
IR - Iran 16
CO - Colombia 15
CL - Cile 14
AZ - Azerbaigian 13
TN - Tunisia 13
UY - Uruguay 10
IL - Israele 9
JM - Giamaica 9
KE - Kenya 9
MY - Malesia 9
NP - Nepal 9
AU - Australia 8
PE - Perù 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
EG - Egitto 6
ET - Etiopia 6
OM - Oman 6
PH - Filippine 6
DZ - Algeria 5
KR - Corea 5
LT - Lituania 5
LV - Lettonia 5
PS - Palestinian Territory 5
RS - Serbia 5
EU - Europa 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NO - Norvegia 4
RO - Romania 4
SA - Arabia Saudita 4
AL - Albania 3
PT - Portogallo 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CH - Svizzera 2
CR - Costa Rica 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
IS - Islanda 2
LB - Libano 2
MD - Moldavia 2
MK - Macedonia 2
MN - Mongolia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
Totale 20.250
Città #
Moscow 1.112
Dublin 1.008
Jacksonville 949
Singapore 871
Ashburn 853
Chandler 659
Nyköping 502
Dallas 474
Hong Kong 445
San Jose 387
Beijing 359
Council Bluffs 251
Dearborn 203
The Dalles 174
Princeton 166
Cambridge 161
Los Angeles 161
Medford 152
Lauterbourg 144
Dong Ket 140
Des Moines 125
Boardman 110
Messina 92
Ann Arbor 83
Buffalo 83
New York 77
São Paulo 77
Lancaster 70
Warsaw 66
Tianjin 65
Jinan 58
Vienna 57
Munich 54
Guangzhou 53
Ho Chi Minh City 52
Woodbridge 51
Wilmington 49
Turku 42
Columbus 41
San Mateo 41
Shenyang 40
Pune 38
Redondo Beach 35
Rio de Janeiro 35
Orem 31
Helsinki 29
Belo Horizonte 28
Brasília 28
Chennai 28
Hangzhou 28
Houston 28
Brooklyn 27
Nanjing 26
Atlanta 25
Abidjan 24
Augusta 24
Frankfurt am Main 24
Montreal 24
Santa Clara 24
Phoenix 22
Tokyo 21
Bremen 20
Campinas 20
Hanoi 20
Nanchang 20
Shanghai 20
Haikou 19
Tashkent 19
Brussels 18
Johannesburg 18
Leawood 18
Chicago 17
London 16
Shenzhen 16
Boston 15
Denver 15
Mumbai 15
Poplar 15
Seattle 15
Zhengzhou 15
Curitiba 14
Hebei 14
Porto Alegre 14
Salvador 14
Ankara 13
Brno 13
Milan 13
San Francisco 13
Stockholm 13
Amsterdam 12
Baku 12
Manchester 12
Ningbo 12
Nuremberg 12
Ardabil 11
Baghdad 10
Casablanca 10
Guarulhos 10
Manaus 10
Mexico City 10
Totale 11.679
Nome #
{ [1.1.1.] CRYPTAND/THYMOL BLUE } : A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES 266
Analysis of the thermal fluctuations in inclusion complexes of genistein with β-cyclodextrin derivatives 256
{[1.1.1.]CRYPTAND/THYMOL BLUE}: A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES ON PH-RATE PROFILE OF DRUGS 227
Nanospheres based on PLGA/amphiphilic cyclodextrin assemblies as potential enhancers of Methylene Blue neuroprotective effect 205
Anticonvulsant agent: enhancement of physicochemical properties 202
CHITOSAN/SULFOBUTHYL ETHER BETA-CYCLODEXTRIN NANOPARTICLES FOR IDEBENONE DELIVERY 198
Isoflavone Aglycons-Sulfobutil Ether-beta-Cyclodextrin Inclusion Complexes: in Solution and Solid State Studies 197
An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidate 195
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 186
Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin 185
A characterization study of resveratrol/sulfobutylether-b-cyclodextrin inclusion complex andin vitro anticancer activity 182
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 180
Comparative photodegradation studies on 3-hydroxyflavone: influence of different media, pH and light sources 177
Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation 175
CARATTERIZZAZIONE DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE MEDIANTE:DSC,RAGGI X,DRIFT,UV-VIS 174
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 174
COMBINED EFFECT OF pH AND CYCLODEXTRINS ON SOLUBILIZATION OF NARINGENIN 170
A STUDY OF THE INCLUSION COMPLEX OF ATENOLOL WITH BETA-CYCLODEXTRIN 169
Acyclovir-b-cyclodextrin prodrugs: an in vitro evaluation for oral administration”. 169
Analytical profile and release of lonidamine from pharmaceutical formulation 169
The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays 169
CORDIA FRANCISCI, C, MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES AS NEW SOURCES OF RUTIN: ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY. 167
DETERMINATION OF FLAVONOIDS BY TURBIDIMETRIC MEASUREMETS 166
AN EXPERIMENTAL DESIGN METHODOLOGY APPLIED TO THE CHIRAL SEPARATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG CANDIDATE 165
PLGA/AMPHIPHILIC CYCLODEXTRIN NANOPARTICLES LOADING METHYLENE BLUE FOR NOSE-TO-BRAIN TARGETING IN ALZHEIMER'S DISEASE 165
COMPARATIVE PHOTODEGRADATION STUDIES: INFLUENCE OF DIFFERENT MEDIA AND LIGHT SOURCES 162
Chitosan nanospheres containing cyclodextrins for idebenone delivery 162
B-Cyclodextrin conjugates for sustained release of drugs 161
Celecoxib-loaded PLGA/cyclodextrin microspheres: Characterization and evaluation of anti-inflammatory activity on human chondrocyte cultures 157
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 156
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 156
CHROMATOGRAPHIC INVESTIGATIONS ON BROTIZOLAM 156
Amphiphilic beta-cyclodextrin nanoparticles encapsulating a carotenoid for drug delivery 156
Nanotherapeutics for anti-inflammatory delivery 156
Direct separation of the enantiomers of reboxetine by liquid chromatography on different cellulose- and amylose-based chiral stationary phases 155
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 154
CONFORMATIONAL SEARCH OF PHENYL SUBSTITUTED GAMMA-LACTAMIC DERIVATIVES. 154
PREPARATION AND CHARACTERIZATION OF GEMCITABINE-LOADED CHITOSAN MICROSPHERES. 154
Optimization of a LC method for the enantio separation of a non-competitive glutamate receptor antagonist, by experimental design methodology 152
ANTIINFLAMMATORY ACTIVITY OF PLANTS IN TRADITIONAL MEDICINE: CORDIA MYXA L., C. FRANCISCI TEN., C. SERRATIFOLIA H.B.K. 152
Rutin-Loaded Solid Lipid Nanoparticles: Characterization and In Vitro Evaluation 151
“Host-guest” interactions in Captisol®/Coumestrol inclusion complex: UV-vis, FTIR-ATR and Raman studies 150
Gemcitabine-Loaded Chitosan Microspheres For Local Delivery In Lung, 149
REAZIONI UV-INDOTTE:FOTOCHIMICA DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE. Nota II 147
RUTIN INCLUSION SYSTEMS WITH ALFA AND BETA-CYCLODEXTRINS: CIRCULAR DICHROISM, UV ABSORPTION SPECTROSCOPY AND ANTIOXIDANT ACTIVITY STUDIES 145
CHIRAL RECOGNITION AND COMPLEXATION BEHAVIOUR OF BETA-CD vs. L- AND D,L-SERINE BY FTIR-ATR SPECTROSCOPY 145
Preparation, characteristics and biological evaluation of micro and nanostructured carriers for controlled release 144
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 142
SPETTRI DI RIFLESSIONE DI FLAVONOIDI DEDOTTI MEDIANTE TRASFORMATA DI KUBELKA-MUNK . 140
GEMCITABINE-LOADED CHITOSAN MICROSPHERES FOR LOCAL DELIVERY IN LUNG 140
INCLUSION COMPLEXES OF SOME FLAVANONES AND THEIR GLYCOSIDES WITH MODIFIED BETA-CYLODEXTRINS 139
METHODS FOR PARTICLE SIZE DETERMINATION IN POWDERS OF PHARMACEUTICAL INTEREST. Nota II 137
Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice 137
Biodegradable microparticles as carrier for moxifloxacine 137
BIODEGRADABLE MICROSPHERES FOR INTRAARTICULAR ADMINISTRATION OF CELECOXIB 137
BETA-CYCLODEXTRIN CONJUGATES FOR SUSTAINED RELEASE OF DRUGS 136
Determination of fludarabine in a pharmaceutical formulation by LC 136
null 135
Phase solubility and FTIR-ATR studies of idebenone/sulfobutyl ether b-cyclodextrin inclusion complex 132
Structural and spectroscopic features of lutein/butanoyl-beta-cyclodextrin nanoassemblies 130
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 130
Effects of alpha and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones 129
Temperature-dependent dynamical evolution in coum/sbe-β-cd inclusion complexes revealed by two-dimensional ftir correlation spectroscopy (2d-cos) 127
Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin 125
Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental design 124
Study of the inclusion complex of atenolol with beta- cyclodextrins 124
Selective reversed-phase liquid chromatography method for the kinetic investigation of 3-hydroxyflavone photostability 123
Solid-state study of polymorphic drugs: carbamazepine 122
MOLECULAR MODELING OF ENANTIOSELECTIVE RECOGNITION BETWEEN GAMMA-LACTAMIC DERIVATIVES AND CHIRALCEL OD CHIRAL STATIONARY PHASE. 121
The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin 121
ISOFLAVONES AND CYCLODEXTRINS: EVIDENCES OF COMPLEXATION BY COMPLEMENTARY SPECTROSCOPIC TECHNIQUES 121
UV-INDUCED REACTIONS:EFFECTS OF MICROENVIROMENT ON FLAVONOIDS PHOTOCHEMISTRY 120
Photochemistry of flavonoids. Solvent effect on photochemical behaviour of 3-hydroxyflavone. 120
PREPARATION AND CHARACTERIZATION OF GEMCITABINE-LOADED CHITOSAN MICROSPHERES 119
HPLC DIASTEREO ED ENANTIOSELETTIVA DI 2-ARIL-4-TIAZOLIDINONI SOSTITUITI. 119
TECNICHE CHEMOMETRICHE PER L'OTTIMIZZAZIONE DI METODOLOGIE STRUMENTALI IN ANALISI FARMACEUTICA 118
New formulation of cyclodextrin nanoassemblies as delivery system for idebenone 118
Gemcitabine anticancer activity enhancement by water soluble celecoxib/ sulfobutyl ether-β-cyclodextrin inclusion complex 118
Chitosan/hyaluronan nanoparticles: a promising tool in cancer immunotherapy 116
null 115
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 113
CORDIA FRANCISCI, C. MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES: A NEW SOURCES OF RUTIN. ANALGESIC AND ANTIINFLAMMATORY ACTIVITY 113
Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation 112
METAL-COMPLEXES OF BENZODIAZEPINES . PART 2. THE REACTION OF 1,4- BENZODIAZEPINES WITH HALIDE-BRIDGED COMPLEXES OF PALLADIUM(II) [PD2X4(PPRN3)2] (X = CL OR I) 111
Diastereo-enantioseparation of N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives on cellulose chiral stationary phases 110
DIRECT ENANTIOMERIC SEPARATION OF REBOXETINE BY LIQUID CHROMATOGRAPHY USING DIFFERENT CELLULOSE AND AMYLOSE BASED CHIRAL STATIONARY PHASES 110
STRUCTURAL AND CONFORMATIONAL STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN COMPLEXES 107
RISOLUZIONE ENANTIOMERICA DI GAMMA-LATTAMI MEDIANTE HPLC. 107
FLUORIMETRIC STUDY OF b-BLOCKERS/b-CYCLODEXTRINS INCLUSION COMPLEXES 106
PHOTODEGRADATION STUDY ON 3-HYDROXYFLAVONE BY HPLC. 105
HPLC-DAD AND TLC OF FLAVONOIDS FROM LEAF EXTRACTIVES OF GENUS CORDIA. 105
Physicochemical properties of inclusion complexes of highly soluble β-cyclodextrins with highly hydrophobic testosterone propionate 105
PHARMACEUTICAL APPLICATION OF BETA-CYCLODEXTRIN: INCLUSION COMPLEXES WITH BETA-BLOCKERS 104
Diastereo-enantioseparation of novel gamma-lactamic derivatives on cellulose chiral stationary phases 103
MOXIFLOXACIN-LOADED CHITOSAN MICROSPHERES FOR INTRAPULMONARY ADMINISTRATION 103
STRUCTURAL AND THERMODYNAMIC STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN INCLUSION COMPLEXES 102
Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies 102
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 102
Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation 102
Dosaggio HPLC della roxatidina, prove di stabilità e rilascio da formulazioni farmaceutiche. 101
Totale 14.393
Categoria #
all - tutte 68.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022887 0 0 16 31 20 2 86 50 5 127 207 343
2022/20232.942 221 213 141 203 266 280 62 172 1.244 17 98 25
2023/2024547 76 105 52 66 53 116 12 21 0 15 2 29
2024/20253.041 48 51 59 192 113 67 40 694 756 187 283 551
2025/20268.570 426 487 579 631 729 2.007 1.145 984 997 319 123 143
2026/2027653 146 461 46 0 0 0 0 0 0 0 0 0
Totale 20.393